Analysis of test results from more than 350,000 people finds older people just as protected as younger
One shot of the Oxford/AstraZeneca or Pfizer/BioNTech vaccine reduces coronavirus infections by nearly two-thirds and protects older and more vulnerable people as much as younger, healthy individuals, a study has found.
The results from Oxford University and the Office for National Statistics are a welcome boost to the vaccination programme and the first to show the impact on new infections and immune responses in a large group of adults in the general population.
